Table 1.

Key clinical characteristics of the patients in each ADPRylation group.

Group
1234
Number of patients (n)91564
Age at diagnosis (years)
 Mean57555054
 Range40–7730–7945–5837–63
Stage at diagnosis
 IIIB1001
 IIIC6953
 IV2610
Mean pretreatment CA-125 (U/mL)2,83211,9041,197767
Type of chemotherapy
 Adjuvant91054
 Neoadjuvant0500
 None received0010
Residual disease
 No gross2310
 Optimal (≤1 cm)5731
 Suboptimal (>1 cm)2523
Platinum status
 Sensitive91352
 Resistant0002
 Refractory0210
Germline BRCA status
 Negative2632
BRCA1 deleterious2300
BRCA2 deleterious0110
BRCA2 VUS1000
 Unknown4522